0,9% Chloride Sodium

DRUG2 trials

Sponsors

Medical University of Warsaw, Can Tho University of Medicine and Pharmacy

Conditions

Dental Plaque and GingivitisPPHNRespiratory FailureTTN

Phase 3

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

Active, not recruitingNCT05527704

Medical University of WarsawPPHN, Respiratory Failure, TTN

Start: 2021-12-31End: 2026-09-30Target: 608Updated: 2025-11-18

The Comparative Effects of Using 0.12% Chlorhexidine and Silver Nanoparticles Mouthwashes in Medical Students

CompletedNCT06963788

Can Tho University of Medicine and PharmacyDental Plaque and Gingivitis

Start: 2024-02-06End: 2024-12-31Updated: 2025-05-09

Related Papers

Protocol for a multicenter, double-blind, randomized, placebo-controlled phase III trial of the inhaled β2-adrenergic receptor agonist salbutamol for transient tachypnea of the newborn (the REFSAL trial)

Frontiers in Pediatrics2023-01-125 citations